Taiwan’s FDA orders recall of ADHD medicine Methydur
Taipei, July 25 (CNA) Taiwan’s Food and Drug Administration (FDA) has ordered the recall of a batch of Methydur Sustained Release Capsules 44mg, a medicine used to treat ADHD, after it failed a dissolution test.